J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mandel, H.
Right arrow Articles by Aviram, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mandel, H.
Right arrow Articles by Aviram, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol 36, 1385-1391, Copyright © 1995 by Lipid Research, Inc.


ARTICLES

Reduced cellular cholesterol content in peroxisome-deficient fibroblasts is associated with impaired uptake of the patient's low density lipoprotein and with reduced cholesterol synthesis

H Mandel, M Getsis, M Rosenblat, M Berant and M Aviram
Department of Pediatrics, Rambam Medical Center, Technion-Faculty of Medicine, Haifa, Israel.

Mammalian cells acquire cellular cholesterol by de novo synthesis as well as by uptake of low density lipoprotein (LDL). Peroxisomes contain enzymes involved in the synthesis of cholesterol, and peroxisome- deficient (PD) patients have been shown to have hypocholesterolemia and abnormal LDL. We therefore decided to study whether cholesterol synthesis and cellular uptake of LDL are impaired in cultured PD fibroblasts. The present study demonstrates a significantly lower cellular cholesterol mass in fibroblasts from three PD patients, as compared to control cells (41-59% of controls). The rate of cholesterol synthesis was also reduced in all three PD cell lines, being 16-20% of the control values. LDL binding and degradation by fibroblasts were 3- to 5-fold higher in the PD cells as compared to control cells. Similarly, enrichment of normal fibroblasts with tetracosanoic acid (C- 24:0), a situation that could mimic the in vivo accumulation of very long chain fatty acid (VLCFA) in PD cells, caused LDL binding and degradation to be 4-fold higher than in non-treated cells. On the other hand, the uptake of LDL derived from PD patients by normal fibroblasts was markedly reduced (by up to 67%) in comparison to the cellular uptake of normal LDL. Similar results were obtained in PD cells. This study demonstrates a lower cellular cholesterol content and reduced cholesterol synthesis rate in PD cell lines. In addition, we demonstrate that regulation of the uptake of normal LDL by cellular LDL receptors is operative in PD cells, whereas LDL derived from PD patients is not recognized normally by the LDL receptor.(ABSTRACT TRUNCATED AT 250 WORDS)
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
J. L. Hargrove, P. Greenspan, and D. K. Hartle
Nutritional Significance and Metabolism of Very Long Chain Fatty Alcohols and Acids from Dietary Waxes
Experimental Biology and Medicine, March 1, 2004; 229(3): 215 - 226.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
W. J. Kovacs, J. E. Shackelford, K. N. Tape, M. J. Richards, P. L. Faust, S. J. Fliesler, and S. K. Krisans
Disturbed Cholesterol Homeostasis in a Peroxisome-Deficient PEX2 Knockout Mouse Model
Mol. Cell. Biol., January 1, 2004; 24(1): 1 - 13.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. Hogenboom, G. J. Romeijn, S. M. Houten, M. Baes, R. J. A. Wanders, and H. R. Waterham
Absence of functional peroxisomes does not lead to deficiency of enzymes involved in cholesterol biosynthesis
J. Lipid Res., January 1, 2002; 43(1): 90 - 98.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
N. Aboushadi, W. H. Engfelt, V. G. Paton, and S. K. Krisans
Role of Peroxisomes in Isoprenoid Biosynthesis
J. Histochem. Cytochem., September 1, 1999; 47(9): 1127 - 1132.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
N. Aboushadi and S. K. Krisans
Analysis of isoprenoid biosynthesis in peroxisomal-deficient Pex2 CHO cell lines
J. Lipid Res., September 1, 1998; 39(9): 1781 - 1791.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
C. L. Baum, E. J. Reschly, A. K. Gayen, M. E. Groh, and K. Schadick
Sterol Carrier Protein-2 Overexpression Enhances Sterol Cycling and Inhibits Cholesterol Ester Synthesis and High Density Lipoprotein Cholesterol Secretion
J. Biol. Chem., March 7, 1997; 272(10): 6490 - 6498.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.